Skip to main content

Peer Review reports

From: Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

Original Submission
9 Jun 2022 Submitted Original manuscript
26 Jun 2022 Reviewed Reviewer Report
27 Jun 2022 Reviewed Reviewer Report - Takao Takeshima
22 Jul 2022 Reviewed Reviewer Report
16 Aug 2022 Author responded Author comments - Patricia Pozo-Rosich
Resubmission - Version 2
16 Aug 2022 Submitted Manuscript version 2
29 Sep 2022 Reviewed Reviewer Report
10 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 Oct 2022 Editorially accepted
25 Oct 2022 Article published 10.1186/s12883-022-02914-9

You can find further information about peer review here.

Back to article page